EUCTR2007-004911-79-BE进行中（未招募）不适用
Pharmacodynamics of Fondaparinux subcutaneous versus continuous intravenous infusion in critically ill patients with or without vasopressors.
cliniques Universitaires st luc-ucl0 个研究点开始时间: 2007年10月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Critically ill patient hospitalized in ICU with or without vasopressors
- •- Age > 18 years
- •- Consent obtained
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- renal insufficiency ( Cr Clearance < 20 ml/min)
- •- treatment with vitamin K antagonist
- •- liver failure (INR > 2)
- •- high risk of bleeding that contraindicate anticoagulant prophylaxis (intracerebral haemorrhage, gastro- intestinal bleeding, …)
- •- severe thrombopenia ( < 30.000/µL)
- •- acute endocarditis
研究者
相似试验
进行中（未招募）
不适用
Fondaparinux population pharmacokinetic to morbid obese patients in post-operatory bariatric surgeryEUCTR2009-016417-15-FRCHU de SAINT-ETIENNE
进行中（未招募）
不适用
Pharmacokinetics and Pharmacodynamics of subcutaneous applied insulin aspart administered with the FlexPen® insulin pen compared to inhaled insulinadministered with the Exubera® deviceEUCTR2007-002060-10-DEikfe GmbH
进行中（未招募）
1 期
Feasibility and effects of subcutaneously given combination of dexmedetomidine and ketamine in ALS patients receiving palliative careAmyotrophic lateral sclerosis (ALS)MedDRA version: 20.1Level: LLTClassification code 10036704Term: Primary lateral sclerosisSystem Organ Class: 100000004852EUCTR2018-000142-18-FITurku University Hospital20
进行中（未招募）
不适用
Safety and efficacy of fondaparinux 1.5 mg in the prevention of venous thromboembolism in medical patients with severe renal insufficiency - NDHospitalized medical patients with moderate to severe renal insufficiency and indication to the use of pharmacological antithrombotic prophylaxisEUCTR2008-005234-79-ITDIPARTIMENTO DI MEDICINA CLINICA - UNIVERSITA` DEGLI STUDI DELL`INSUBRIA
已完成
3 期
Phase III study of efficacy of fondaparinux on the prevention of post-operative venous thromboembolism in patients undergoing with laparoscopic colorectal cancer surgery.Colorectal cancersJPRN-UMIN000008435Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group300